Literature DB >> 17550958

Ghrelin suppresses secretion of luteinizing hormone in humans.

Michael Kluge1, Petra Schüssler, Manfred Uhr, Alexander Yassouridis, Axel Steiger.   

Abstract

CONTEXT: Ghrelin affects the hypothalamic-pituitary-gonadal axis in various nonhuman mammalians, predominantly by suppressing secretion of LH. However, for humans, no such evidence exists.
OBJECTIVE: Our objective was to study the effect of ghrelin on secretion of LH and testosterone in humans. DESIGN, PARTICIPANTS, AND INTERVENTION: Nocturnal (2000-0700 h) secretion profiles of LH and testosterone were determined in 10 healthy males (25.7 +/- 3.0 yr) twice, receiving 50 microg ghrelin or placebo at 2200, 2300, 2400, and 0100 h, in this single-blind, randomized, cross-over study.
RESULTS: Ghrelin was associated with significantly (P < 0.05) lower mean plasma levels of both LH (2340-0200 h) and testosterone (0040-0300 h) than placebo. LH peak levels of the pulse after first administration of ghrelin/placebo were significantly (P = 0.014) smaller in the ghrelin (2.98 +/- 1.34 mIU/ml) than in the placebo condition (4.37 +/- 1.09 mIU/ml). In addition, the interval between this and the preceding peak was significantly (P = 0.010) longer in the ghrelin (255.8 +/- 79.1 min) than in the placebo condition (190.8 +/- 51.0 min). Significantly (P = 0.005) more LH pulses occurred with placebo (3.2 +/- 0.75) than ghrelin (2.6 +/- 0.7) subsequent to ghrelin/placebo administration.
CONCLUSIONS: Ghrelin caused both a delay and suppression of the amplitude of LH pulses. These findings are in accordance with those in nonhuman mammalians.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17550958     DOI: 10.1210/jc.2007-0593

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  31 in total

Review 1.  Body composition and skeletal health: too heavy? Too thin?

Authors:  Alexander Faje; Anne Klibanski
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

Review 2.  Bone density in the adolescent athlete.

Authors:  Madhusmita Misra
Journal:  Rev Endocr Metab Disord       Date:  2008-04-12       Impact factor: 6.514

Review 3.  The neuroendocrine basis of anorexia nervosa and its impact on bone metabolism.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Neuroendocrinology       Date:  2011-01-13       Impact factor: 4.914

Review 4.  The endocrine manifestations of anorexia nervosa: mechanisms and management.

Authors:  Melanie Schorr; Karen K Miller
Journal:  Nat Rev Endocrinol       Date:  2016-11-04       Impact factor: 43.330

Review 5.  Endocrine consequences of anorexia nervosa.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Lancet Diabetes Endocrinol       Date:  2014-04-02       Impact factor: 32.069

Review 6.  20 years of leptin: leptin and reproduction: past milestones, present undertakings, and future endeavors.

Authors:  Farid F Chehab
Journal:  J Endocrinol       Date:  2014-08-12       Impact factor: 4.286

7.  An eGFP-expressing subpopulation of growth hormone secretagogue receptor cells are distinct from kisspeptin, tyrosine hydroxylase, and RFamide-related peptide neurons in mice.

Authors:  Jeremy T Smith; Alex Reichenbach; Moyra Lemus; Bharath K Mani; Jeffrey M Zigman; Zane B Andrews
Journal:  Peptides       Date:  2013-07-04       Impact factor: 3.750

Review 8.  Neuroendocrine consequences of anorexia nervosa in adolescents.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Endocr Dev       Date:  2009-11-24

Review 9.  Clinical review: The human experience with ghrelin administration.

Authors:  Margaret C Garin; Carrie M Burns; Shailja Kaul; Anne R Cappola
Journal:  J Clin Endocrinol Metab       Date:  2013-03-26       Impact factor: 5.958

10.  Astressin B, a nonselective corticotropin-releasing hormone receptor antagonist, prevents the inhibitory effect of ghrelin on luteinizing hormone pulse frequency in the ovariectomized rhesus monkey.

Authors:  Nicolas R Vulliémoz; Ennian Xiao; Linna Xia-Zhang; Jean Rivier; Michel Ferin
Journal:  Endocrinology       Date:  2007-12-06       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.